NCT04219085View on ClinicalTrials.gov

CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
Gestational DiabetesMaternal Complication of Pregnancy
Interventions
DEVICE

Continuous Glucose Monitor

Wearing of a continuous glucose monitor to monitor blood glucose levels in women with gestational diabetes

OTHER

Routine Care

Use of a glucometer to monitor blood glucose levels in women with gestational diabetes

Trial Locations (1)

06511

Yale University, New Haven

All Listed Sponsors
lead

Yale University

OTHER

NCT04219085 - CAPO: Continuous Glucose Monitoring in A2 Gestational Diabetes and Pregnancy Outcomes | Biotech Hunter | Biotech Hunter